ZANABONI, ANNA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 486
EU - Europa 256
AS - Asia 160
OC - Oceania 1
SA - Sud America 1
Totale 904
Nazione #
US - Stati Uniti d'America 482
IE - Irlanda 182
CN - Cina 153
IT - Italia 25
FI - Finlandia 16
DE - Germania 10
SE - Svezia 6
UA - Ucraina 5
CA - Canada 4
GB - Regno Unito 4
BE - Belgio 3
HU - Ungheria 2
TR - Turchia 2
AT - Austria 1
AU - Australia 1
BR - Brasile 1
CH - Svizzera 1
ES - Italia 1
HK - Hong Kong 1
IN - India 1
IR - Iran 1
SA - Arabia Saudita 1
VN - Vietnam 1
Totale 904
Città #
Dublin 182
Chandler 168
Ashburn 45
Nanjing 32
Beijing 30
Lawrence 24
Medford 24
Princeton 24
Jacksonville 17
Nanchang 14
Shanghai 14
Wilmington 13
Changsha 12
Hebei 11
Jiaxing 11
Ann Arbor 10
Helsinki 10
Shenyang 9
Hangzhou 8
Washington 6
Los Angeles 5
Tianjin 5
Norwalk 4
Brussels 3
Milan 3
Redwood City 3
Rivoli 3
Seattle 3
Toronto 3
Turin 3
Woodbridge 3
Borås 2
Des Moines 2
Fairfield 2
Jinan 2
New York 2
Orange 2
Pavia 2
Adliswil 1
Berlin 1
Budapest 1
Central 1
Concorezzo 1
Dearborn 1
Düsseldorf 1
Hanoi 1
Houston 1
Melbourne 1
Qingdao 1
Riyadh 1
San Francisco 1
Shenzhen 1
São Paulo 1
Vienna 1
Winnipeg 1
Zanjan 1
Zhengzhou 1
Totale 735
Nome #
Microarray analysis on peripheral blood mononuclear cells of coeliac patients 77
Blocco combinato di coattivazione e costimolazione: una strategia utile nell'induzione di tolleranza alloantigene - specifica 57
Endothelial nitric oxide synthase inhibition triggers inflammatory responses in the brain of male rats exposed to ischemia-reperfusion injury 53
The role of the transient receptor potential ankyrin type-1 (TRPA1) channel in migraine pain: evaluation in an animal model 52
Effects of kynurenic acid analogue 1 (KYNA-A1) in nitroglycerin-induced hyperalgesia: Targets and anti-migraine mechanisms 49
Microarray analysis of peripheral blood mononuclear cells in coeliac disease 47
Inhibition of monoacylglycerol lipase: Another signalling pathway for potential therapeutic targets in migraine? 45
Endocannabinoid system and migraine pain: An update 42
Chronic and intermittent administration of systemic nitroglycerin in the rat induces an increase in the gene expression of CGRP in central areas: potential contribution to pain processing 40
Nitroglycerin as a comparative experimental model of migraine pain: From animal to human and back 38
FAAH inhibition as a preventive treatment for migraine: A pre-clinical study 38
Neurophysiological and biomolecular effects of erenumab in chronic migraine: An open label study 35
Antagonism of transient receptor potential ankyrin type-1 channels as a potential target for the treatment of trigeminal neuropathic pain: Study in an animal model 33
Characterization of CB2 Receptor Expression in Peripheral Blood Monocytes of Acute Ischemic Stroke Patients 31
Modulation of cerebral RAGE expression following nitric oxide synthase inhibition in rats subjected to focal cerebral ischemia 30
Effects of kynurenic acid analogue 1 (KYNA-A1) in nitroglycerin-induced hyperalgesia: Targets and anti-migraine mechanisms 30
Double-Binding Botulinum Molecule with Reduced Muscle Paralysis: Evaluation in In Vitro and In Vivo Models of Migraine 30
Spinal nociceptive sensitization and plasma palmitoylethanolamide levels during experimentally induced migraine attacks 29
Expression of selected microRNAs in migraine: A new class of possible biomarkers of disease? 28
Characterization of the peripheral FAAH inhibitor, URB937, in animal models of acute and chronic migraine 27
Dual inhibition of faah and magl counteracts migraine-like pain and behavior in an animal model of migraine 24
Cd163 as a potential biomarker of monocyte activation in ischemic stroke patients 22
Plasma levels of CGRP and expression of specific microRNAs in blood cells of episodic and chronic migraine subjects: towards the identification of a panel of peripheral biomarkers of migraine? 21
Peripheral changes of endocannabinoid system components in episodic and chronic migraine patients: A pilot study 20
Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine 17
Potentiation of endocannabinoids and other lipid amides prevents hyperalgesia and inflammation in a pre-clinical model of migraine 8
Activity of FAAH-Inhibitor JZP327A in an Experimental Rat Model of Migraine 7
Totale 930
Categoria #
all - tutte 4.120
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.120


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 0 1 2
2019/2020148 44 64 0 2 1 1 0 3 0 7 26 0
2020/202132 2 1 0 5 2 4 3 9 0 5 1 0
2021/2022113 1 0 1 7 0 1 3 9 3 2 14 72
2022/2023442 34 21 19 33 31 49 0 30 204 3 13 5
2023/2024142 22 21 8 13 14 39 1 13 3 8 0 0
Totale 930